Enroll In Clinical Trials Through Your IPhone
In a surprise announcement Monday, Apple unveiled a biomedical platform called ResearchKit that will allow any iPhone user to enroll in tests of new drugs and therapies by downloading apps from hospitals and providers who are recruiting patients. Meanwhile, Reston-based Maximus announces plans to acquire information technology contractor Acentia.
Politico:
Accompanying Apple Watch, A Medical Surprise
And now, Apple will enroll you in a clinical trial. In a surprise announcement that overshadowed the presentation of its new Apple Watch — for the health care industry, at least — the Silicon Valley giant on Monday unveiled a new biomedical platform called ResearchKit. The platform ... will allow any iPhone user to enroll in tests of new drugs and therapies by downloading apps from hospitals and providers who are recruiting patients.
(Gold, 3/10)
The Washington Post:
Maximus, Seeking To Expand Into Health IT Market, Acquires Acentia
Reston-based contractor Maximus said this week that it will acquire information technology contractor Acentia for $300 million cash as it seeks to expand more into the federal space. The deal signals a concerted step into the federal health IT market for a company better known for processing Medicare claims for state governments and running call centers for state health exchanges. (Gregg, 3/10)
